Business Description
PaxMedica Inc
NAICS : 541714
SIC : 2833
ISIN : US70424C2035
Share Class Description:
PXMD: Ordinary SharesDescription
PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (COVID-19). The company's product candidate under development is PAX-101, an intravenous formulation of suramin, which it is developing for multiple indications, including East African HAT, ASD, ME/CFS, and LCS.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.27 | |||||
9-Day RSI | 47.35 | |||||
14-Day RSI | 48.72 | |||||
6-1 Month Momentum % | 600 | |||||
12-1 Month Momentum % | 600 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | 0.03 | |||||
EV-to-EBITDA | 0.03 | |||||
EV-to-FCF | 0.05 | |||||
Earnings Yield (Greenblatt) % | 3333.33 | |||||
FCF Yield % | -12093.65 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PXMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PaxMedica Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.79 | ||
| Beta | -59.6279 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 12.28 | ||
| Volatility % | 4882 | ||
| 14-Day RSI | 48.72 | ||
| 14-Day ATR ($) | 0.00005 | ||
| 20-Day SMA ($) | 0.00052 | ||
| 12-1 Month Momentum % | 600 | ||
| 52-Week Range ($) | 0.0001 - 0.02 | ||
| Shares Outstanding (Mil) | 126.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PaxMedica Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PaxMedica Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2024 | 2024-08-09 | 0.22 (+4.79%) | ||
| 0.0588235:1 Stock Split | 2023-10-31 | 2.82 (-7.89%) |
Show
Entries
PaxMedica Inc Frequently Asked Questions
What is PaxMedica Inc(PXMD)'s stock price today?
The current price of PXMD is $0.00. The 52 week high of PXMD is $0.02 and 52 week low is $0.00.
When is next earnings date of PaxMedica Inc(PXMD)?
The next earnings date of PaxMedica Inc(PXMD) is .
Does PaxMedica Inc(PXMD) pay dividends? If so, how much?
PaxMedica Inc(PXMD) does not pay dividend.
Guru Commentaries on OTCPK:PXMD
No articles.
Press Release
Articles on PaxMedica Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers